[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.142.219. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Evidence-Based Dermatology: Research Commentary
September 2004

Twice-Weekly Topical Corticosteroid Therapy May Reduce Atopic Dermatitis Relapses

Author Affiliations
 

Michael E.BigbyMDRosamariaCoronaDSc, MDDamianoAbeniMD, MPHAlexandra B.KimballMD, MPHMoysesSzkloMD, MPH, DrPHHywelWilliamsMSc, PhD, FRCP

Arch Dermatol. 2004;140(9):1151-1152. doi:10.1001/archderm.140.9.1151

Commentary on: Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study

Berth-Jones J, Damstra RJ, Golsch S, Livden JK, Van Hooteghem O, Allegra F, Parker CA

BMJ. 2003;326:1367-1370

Question: How effective and safe is the addition of twice-weekly fluticasone propionate cream or ointment to regular emollient therapy for reducing relapses in people with chronic relapsing atopic dermatitis (AD)?

First Page Preview View Large
First page PDF preview
First page PDF preview
×